4/A//SEC Filing
Flynn James P 4/A
Accession 0000950170-24-004228
CIK 0001262104other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:00 PM ET
Size
8.1 KB
Accession
0000950170-24-004228
Insider Transaction Report
Form 4/AAmended
MEI Pharma, Inc.MEIP
Flynn James P
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-12-18+6,700→ 6,700 totalExercise: $6.19Exp: 2033-12-18→ Common Stock (6,700 underlying) - Award
Stock Option (Right to Buy)
2023-12-18+10,000→ 10,000 totalExercise: $6.19Exp: 2033-12-18→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Such option shall be vested and exercisable with respect to 12.5% of the shares on the date of grant and the remainder of the option will vest and become exercisable in equal monthly amounts of 12.5% of the shares subject to the option, beginning on the first day of each calendar month following the date of grant (January 1, 2024) and continuing through July 1, 2024 with full vesting on July 1, 2024, subject to continued service through the applicable vesting date.
- [F2]Such option shall vest and become exercisable in 36 equal monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001955965
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:00 PM ET
- Size
- 8.1 KB